The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.

Richard Hanks Biography and Net Worth

CFO of Clarivate

Richard joined Clarivate Analytics in February 2017 as its Chief Financial Officer where he manages the global financial organization and leads the development and execution of the company’s fiscal strategies. Prior to Clarivate, Richard was the CFO at BDP International Inc. for four years. Before that he was at Infogroup Inc. Richard is achartered accountant and trained with PriceWaterhouseCoopers in the UK, where he holds British citizenship.
Richard is a graduate of the University of Nottingham Business School with an honors degree in Industrial Economics.

What is Richard Hanks' net worth?: The estimated net worth of Richard Hanks is at least $701,582.40 as of June 14th, 2021. Mr. Hanks owns 140,880 shares of Clarivate stock worth more than $701,582 as of December 21st. This net worth estimate does not reflect any other investments that Mr. Hanks may own. Learn More about Richard Hanks' net worth.
How do I contact Richard Hanks?: The corporate mailing address for Mr. Hanks and other Clarivate executives is 160 Blackfriars Road, London X0, SE1 8EZ. Clarivate can also be reached via phone at 442074334000 and via email at [email protected]. Learn More on Richard Hanks' contact information.
Has Richard Hanks been buying or selling shares of Clarivate?: Richard Hanks has not been actively trading shares of Clarivate during the last quarter. Most recently, Richard Hanks sold 124,297 shares of the business's stock in a transaction on Monday, June 14th. The shares were sold at an average price of $26.00, for a transaction totalling $3,231,722.00. Following the completion of the sale, the chief financial officer now directly owns 140,880 shares of the company's stock, valued at $3,662,880. Learn More on Richard Hanks' trading history.
Who are Clarivate's active insiders?: Clarivate's insider roster includes Mukhtar Ahmed (Insider), Richard Hanks (CFO), Richard Roedel (Director), Saurabh Saha (Director), James Samson (Insider), Andrew Snyder (Director), Bar Veinstein (Insider), and Sheryl von Bluchder (Director). Learn More on Clarivate's active insiders.
Are insiders buying or selling shares of Clarivate?: In the last year, Clarivate insiders bought shares 3 times. They purchased a total of 2,293,938 shares worth more than $11,794,219.62. In the last year, insiders at the sold shares 3 times. They sold a total of 197,646 shares worth more than $1,379,110.50. The most recent insider tranaction occured on November, 22nd when Director Michael J Angelakis bought 765,000 shares worth more than $3,970,350.00. Insiders at Clarivate own 23.1% of the company. Learn More about insider trades at Clarivate.
Information on this page was last updated on 11/22/2024.

Richard Hanks Insider Trading History at Clarivate

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
6/14/2021	Sell	124,297	$26.00	$3,231,722.00	140,880

Richard Hanks Buying and Selling Activity at Clarivate

Clarivate Company Overview

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets. In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.

Today's Range

Now: $4.98

$4.82

$5.07

50 Day Range

MA: $5.68

$4.33

$6.83

2 Week Range

Now: $4.98

$4.25

$9.60

Volume

6,610,482 shs

Average Volume

4,601,417 shs

Market Capitalization

$3.54 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.12

First JFK… next Elon?

From Porter & Company | Ad

Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.

I share with you in this special investigative documentary.